Immunogenicity and safety in infants of a DTwPHib full liquid vaccine

Acta Paediatrica, International Journal of Paediatrics

Volumn 92, Issue 5, 2003, Pages 541-545

  Botet Asensi, F I ^a   Veronese, A ^b   Del Carmen Otero, M ^a   Desamparados Tamarit Perez M ^a   Hontangas Lopez, J L ^a   Viviani, S ^b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b CHIRON VACCINES   (Italy)

Author keywords

Combined vaccines; Diphtheria tetanus pertussis; DTwPHib; Haemophilus influenzae type b CRM197 conjugate

Indexed keywords

ANALGESIC AGENT; ANTIPYRETIC AGENT; BEHRING DTP; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; VAXEM 4; VAXEMHIB;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIPHTHERIA; DRUG CONJUGATION; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; ERYTHEMA; FEVER; HUMAN; IMMUNOGENICITY; INFANT; INFLUENZA; INJECTION; IRRITABILITY; LONG TERM CARE; MOOD DISORDER; NORMAL HUMAN; PERTUSSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN INDURATION; SOMNOLENCE; SPAIN; TETANUS; VACCINATION; VOMITING;

ANTIBODIES; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; FOLLOW-UP STUDIES; HAEMOPHILUS VACCINES; HUMANS; IMMUNITY; IMMUNIZATION SCHEDULE; IMMUNOGENETICS; INFANT; POLYSACCHARIDES, BACTERIAL; TIME FACTORS; VACCINES, COMBINED;

EID: 0042421977     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035320310001581     Document Type: Article

References (18)

1. Rosenberg Z, Findley S, McPhillips S, Penachio M, Silver P. Community-based strategies for immunizing the "hard-to-reach" child: the New York State immunization and primary health care initiative. Am J Prev Med 1995; 11 Suppl 3: 14-20
2. Anon. Recommended childhood immunization schedule - United States, 2000. MMWR Morb Mortal Wkly Rep 2000; 49: 35-3847
3. Centers for Disease Control and Prevention. Recommended childhood immunization schedule - United States, 2001. JAMA 2001; 285: 875-6
4. Anon. Combination vaccines for childhood immunization. MMWR Morb Mortal Wkly Rep 1999; 48 RR-5: 1-14
5. Pines E, Barrand M, Fabre P, et al. New acellular pertussis-containing paediatric combined vaccines. Vaccine 1999; 17: 1650-6
6. Kanra G, Viviani S, Yurdakök K, et al. Safety, tolerability and immunogenicity of a Haemophilus influenzae type b vaccine containing aluminum phosphate adjuvant administered at 2, 3 and 4 months of age. Turk J Pediatr 1999; 42: 421-7
7. Mariani M, Luzzi E, Proietti D, et al. A competitive enzyme-linked immunosorbent assay for measuring the levels of serum antibody to Haemophilus influenzae type b. Clin Diagn Lab Immunol 1988: 667-74
8. Knutsson N, Trollfors B, Taranger J, et al. Immunogenicity and reactogenicity of diphtheria, tetanus and pertussis toxoids combined with inactivated polio vaccine, when administered concomitantly with or as a diluent for a Hib conjugate vaccine. Vaccine 2001; 19: 4396-403
9. Eskola J, Ward J, Dagan R, Goldblatt D, Zepp F, Siegrist CA. Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis. Lancet 1999; 354: 2063-8
10. Greenberg DP, Wong VK, Partridge S, et al. Immunogenicity of a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine when mixed with a diphtheria-tetanus-acellular pertussis-hepatitis B combination vaccine. Pediatr Infect Dis J 2000; 19: 1135-40
11. Hoppenbrouwers K, Lagos R, Swennen B, et al. Safety and immunogenicity of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-pertussis (DTP) combination vaccine administered in a dual-chamber syringe to infants in Belgium and Chile. Vaccine 1998; 16: 921-7
12. Hoppenbrouwers K, Roelants M, Ethevenaux C, Vandermeulen C, Knops J, Desmyter J. The effect of reconstitution of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) vaccine on the immune responses to a diphtheria-tetanus-whole cell pertussis (DTwP) vaccine: a five-year follow-up. Vaccine 1999; 17: 2588-98
13. Araujo OO, Forleo-Neto E, Vespa GN, et al. Associated or combined vaccination of Brazilian infants with a conjugate Haemophilus influenzae type b (Hib) vaccine, a diphtheria-tetanus-whole-cell pertussis vaccine and IPV or OPV elicits protective levels of antibodies against Hib. Vaccine 2000; 19: 367-75
14. Usonis V, Bakasenas V. Does concomitant injection of a combined diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated polio virus vaccine influence the reactogenicity and immunogenicity of commercial Haemophilus influenzae type b conjugate vaccines? Eur J Pediatr 1999; 158: 398-402
15. Clemens JD, Ferreccio C, Levine MM, et al. Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine. JAMA 1992; 267: 673-8
16. Paradiso PR, Hogerman DA, Madore DV, et al. Safety and immunogenicity of a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine in young infants. Pediatrics 1993; 92: 827-32
17. Levine OS, Lagos R, Losonsky GA, et al. No adverse impact on protection against pertussis from combined administration of Haemophilus influenzae type b conjugate and diphtheria-tetanus toxoid-pertussis vaccines in the same syringe. J Infect Dis 1996; 174: 1341-4
18. World Health Organization. Global programme for vaccines and immunization. Expanded programme on immunization policy. Geneva: WHO; 1996